A recent review has identified that myostatin may play an important role in contributing to the negative cycle of obesity by not only adversely regulating muscle mass but also reducing lipid oxidation and insulin sensitivity [239]. This evidence concerns the gene MSTN and obesity due to melanocortin 4 receptor deficiency.